ClinicalTrials.gov
ClinicalTrials.gov Menu

A Trial to Evaluate the Safety and Efficacy of Elamipretide in Subjects With Primary Mitochondrial Myopathy Followed by an Open-Label Extension (MMPOWER-3)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03323749
Recruitment Status : Enrolling by invitation
First Posted : October 27, 2017
Last Update Posted : April 6, 2018
Sponsor:
Information provided by (Responsible Party):
Stealth BioTherapeutics Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Enrolling by invitation
  Estimated Primary Completion Date : January 2019
  Estimated Study Completion Date : December 2020